This content is machine translated Systemic Lupus Erythematosus New weapons in the fight against SLE Systemic Lupus Erythematosus (SLE) is often a major challenge not only for those affected, but also for physicians. Despite numerous therapeutic options, treatment is usually a tightrope walk between dangerous…
View Post 4 min This content is machine translated Psoriasis and psoriatic arthritis Secukinumab as a treatment option in pediatric patients – an update. Children and adolescents affected by psoriasis and/or psoriatic arthritis often suffer a great deal. Particularly in cases of severe symptoms, the quality of life of those affected and their families…
View Post 3 min This content is machine translated ASC Nanobodies New approach against chronic inflammation Researchers at the Universities of Bonn and Sao Paulo have succeeded in curbing chronic inflammation in mice. They used customized “mini-antibodies” for this purpose. With these nanobodies, they succeeded in…
View Post 3 min This content is machine translated ANCA-associated vasculitis New standard drugs and less cortisone For patients with ANCA-associated vasculitis, one of the most severe rheumatic diseases, treatment options have improved in recent years. Biologics therapies are also gaining ground in these rare diseases. These…
View Post 4 min This content is machine translated Psoriatic Arthritis 5-year long-term data on apremilast are convincing Many patients with psoriatic arthritis (PsA) suffer from chronic symptoms and need permanent relief from their symptoms. Two pooled analyses based on data from the PALACE trial program show that…
View Post 3 min This content is machine translated Recommendations of the DGRh Interrupt rheumatism therapy only briefly before operations The increased risk of infection after surgical procedures necessitates temporary adjustment of basic anti-inflammatory therapy in patients with rheumatic diseases. However, medication breaks may be shortened based on new study…
View Post 3 min This content is machine translated Long-term management of psoriasis Biologics have improved the supply situation Psoriasis registries and care studies are an important source of data for evidence-based systems therapy. Convincing long-term data are now available, particularly for the anti-IL-17 and anti-IL-23 antibodies. These have also…
View Post 3 min This content is machine translated Intestinal germs and rheumatism How the microbiome influences disease propensity The human intestine is home to an entire ecosystem of bacteria, fungi, viruses and other microorganisms. Weighing up to two kilograms, this biocoenosis is virtually an organ within an organ…
View Post 4 min Interview with the awardee of the AbbVie Rheumatology Fellowship 2021 “I love doing research in the field of rheumatology” The AbbVie Rheumatology Fellowship has supported training of young researchers since 2004. Learn more about how it is helping last year’s awardee, Dr. med. Cosimo Bruni, University Hospital Zurich, to…
View Post 3 min This content is machine translated Plaque psoriasis 5-Year Data on Ixekizumab: Patients Benefit Over the Long Term Continuous therapy with the anti-IL17 antibody ixekizumab has shown sustained long-term improvements in itch, skin pain, and health-related quality of life in patients with moderate to severe plaque psoriasis. Patients…
View Post 4 min This content is machine translated Inflammatory rheumatic diseases Targeted therapy in AS and PsA in use for over a year [1]. Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) can cause permanent joint damage and significantly reduce the quality of life of those affected [2, 3]. For more than a year, an…
